Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement

@inproceedings{Meybohm2013ReevaluatingCA,
  title={Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement},
  author={Patrick Meybohm and Hugo K. Van Aken and Andrea De Gasperi and Stefan G. De Hert and Giorgio Della Rocca and Armand R J Girbes and Hans Gombotz and Bertrand Guidet and Walter R. Hasibeder and Markus W Hollmann and Can Ince and Matthias W Jacob and Peter R. Kranke and Sibylle A. Kozek-Langenecker and Stephan Alexander Loer and Claude D Martin and Martin Siegemund and Christian Wunder and Kai Zacharowski},
  booktitle={Critical care},
  year={2013}
}
INTRODUCTION Hydroxyethyl starch (HES) is a commonly used colloid in critically ill patients. However, its safety has been questioned in recent studies and meta-analyses. METHODS We re-evaluated prospective randomised controlled trials (RCT) from four meta-analyses published in 2013 that compared the effect of HES with crystalloids in critically ill patients, focusing on the adherence to 'presumably correct indication'. Regarding the definition of 'presumably correct indication', studies were… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 11 times over the past 90 days. VIEW TWEETS
29 Citations
41 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 41 references

BaSES Trial: Basel Starch Evaluation in Sepsis

  • M Siegemund
  • ClinicalTrialsgov Identifier:
  • 2013
Highly Influential
9 Excerpts

Similar Papers

Loading similar papers…